Context Modern management of differentiated thyroid cancer requires individualized care
plans that tailor the intensity of therapy and follow-up to the estimated risks of recurrence …

Differentiated thyroid carcinoma (DTC) is the most common endocrine cancer. Particularly
the incidence of small clinically indolent tumors has been increasing significantly during the …

Background Risk stratification for patients with differentiated thyroid cancer (DTC) is based
primarily on pathologic tumor characteristics. Accurate preoperative prognostication could …

Purpose Lung metastasis (LM) is one of the most frequent distant metastases of thyroid
cancer (TC). This study aimed to develop a machine learning algorithm model to predict …

OBJECTIVE. The paradigm of theranostics is based on tailoring therapy for the purpose of
optimizing outcomes. This principle is being applied to radioactive iodine therapy …

Background: The 2015 American Thyroid Association (ATA) guidelines proposed a three-
category system for estimating the risk of recurrence of differentiated thyroid carcinoma …

Background: Differentiated thyroid cancer (DTC) is the only cancer entity for which the
UICC/AJCC (Union for International Cancer Control and American Joint Committee on …

Background: The morbidity of papillary thyroid carcinoma (PTC) is primarily related to
locoregional recurrences and distant metastases. The definition of minimal extrathyroidal …

Background The effects of subclinical hyperthyroidism on bone mineral density (BMD)
induced by thyroid-stimulating hormone (TSH) suppression therapy in patients with …

The treatment of differentiated thyroid cancer continues to move away from a 'one size fits
all'approach to a process of tailored therapeutic decision-making that incorporates disease …